FDA Inspection 1226812 — CMAX Clinical Research Pty Ltd
The FDA completed an inspection of CMAX Clinical Research Pty Ltd on Nov 10, 2023 in Adelaide. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 10, 2023
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Adelaide (Australia)
Additional details
Clinical BA/BE